Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.
Differential vascular remodeling is one of the major mechanisms of heterogeneity in atherosclerosis. The structural and functional heterogeneity between arteries and veins determines the degree of vascular remodeling. Matrix metalloproteases (MMPs) and their tissue inhibitors (TIMPs) play key roles in vascular structural and functional remodeling. We hypothesized that the level of blood flow in different arteries and veins caused structural and functional heterogeneity that ultimately determined potential vascular remodeling. To test this hypothesis, in vivo blood flow and blood pressure in the aorta, carotid, femoral artery, and femoral vein was measured in male Sprague-Dawley rats (weight 380-400 gm). Arterial and venous pressures were measured by PE-50 catheter cannulation. Blood flow was measured by a transonic ultrasound system. The aortic arch, femoral and carotid arteries, and abdominal vena cava were isolated to determine the expression of MMP-2, -9, -12, and -13 and TIMP-1, -3, and -4 by Western blot and in gelatin gel zymography. Masson trichrome and van Gieson stains were used to stain the histologic tissue sections. The results revealed that blood flow was higher in the aorta and carotid artery than the femoral artery and vein. MMP-9 and MMP-13 were higher in the carotid artery in comparison with the other blood vessels, while TIMP-3 showed higher expression in the aorta than the arteries. Further, the MMP-9 activity was significantly higher in the carotid artery than in the aorta and femoral artery. There was a higher degree of basement membrane collagen in the femoral artery and therefore a low elastin: collagen ratio, while in the carotid artery a higher level of elastin and, therefore, a high elastin: collagen ratio was found. The results suggested that medial thickness and elastin:collagen ratios had a threshold in blood flow in the range 0.6-2.5 mL/min, which increased robustly if blood flow increased to 2.7 mL/min. This pattern was inverted by the total MMP:TIMP ratio. We conclude that vascular remodeling is a function of rate of blood flow, which would in turn be determined by the amounts of MMPs and their inhibitors present. The study combined the endothelial and dynamic (blood flow/pressure) components that affect medial thickness and elastin: collagen ratios.
Basu
Poulami
P
Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Sen
Utpal
U
Tyagi
Neetu
N
Tyagi
Suresh C
SC
D000818:Animals; D001011:Aorta / Q000502:physiology; D017536:Carotid Artery, Common / Q000502:physiology; D004549:Elastin / Q000502:physiology*; D005263:Femoral Artery / Q000502:physiology; D005268:Femoral Vein / Q000502:physiology; D008297:Male; D020782:Matrix Metalloproteinases / Q000502:physiology*; D051381:Rats; D012039:Regional Blood Flow / Q000502:physiology*; D019714:Tissue Inhibitor of Metalloproteinases / Q000502:physiology*
D019714:Tissue Inhibitor of Metalloproteinases; D004549:Elastin; D020782:Matrix Metalloproteinases
Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H684-93
16980344
Hepatology. 2005 May;41(5):1074-84
15841469
Circ Res. 1967 Dec;21(6):901-18
6078150
Circulation. 2006 Jun 27;113(25):2936-42
16801474
Am Heart J. 1999 Nov;138(5 Pt 2):S419-20
10539839
Biochem Pharmacol. 2008 Jan 15;75(2):346-59
17678629
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83
10708863
Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2438-48
17237246
J Biol Chem. 1993 Aug 5;268(22):16513-8
8344932
Circulation. 2000 Oct 17;102(16):1874-6
11034930
Proc R Soc Lond B Biol Sci. 1957 Jun 25;146(925):541-51
13441679
Physiol Rev. 1995 Jul;75(3):519-60
7624393
Am J Physiol. 1989 Apr;256(4 Pt 2):H931-9
2705563
Matrix Biol. 2000 Nov;19(6):471-80
11068201
J Cell Sci. 1994 Sep;107 ( Pt 9):2373-9
7844157
Ann N Y Acad Sci. 1992 Dec 26;673:321-30
1485729
Cardiovasc Res. 2006 Feb 15;69(3):562-73
16405877
Curr Hypertens Rep. 2003 Dec;5(6):466-72
14594565
Physiol Rev. 2005 Jan;85(1):1-31
15618476
J Anat. 1972 Oct;113(Pt 1):17-34
4648480
Respirology. 2009 Jan;14(1):46-52
19144048
Biochim Biophys Acta. 1992 Dec 8;1156(1):57-61
1472539
Hypertension. 2005 Mar;45(3):432-7
15655118
Cardiovasc Diabetol. 2005 Jun 28;4:9
15985157
Neurochem Int. 2008 Dec;53(6-8):214-9
18725259
J Cereb Blood Flow Metab. 2009 Sep;29(9):1547-58
19513084
Rev Esp Cardiol. 2005 Jun;58(6):615-7
15970115
Am J Cardiol. 2006 Jul 17;98(2A):2H-15H
16843744
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1799-805
16709939
J Anat. 2002 Jan;200(Pt 1):97-103
11837253
Hypertension. 1999 Jan;33(1):116-23
9931091
Cardiovasc Res. 2003 Oct 1;59(4):812-23
14553821
J Pathol. 2007 Jan;211(2):157-72
17200940
Am J Physiol Renal Physiol. 2009 Aug;297(2):F410-9
19474193
J Cell Biol. 2004 Nov 22;167(4):757-67
15545316
Cardiovasc Res. 2006 Feb 15;69(3):585-94
16426591
Clin Chem Lab Med. 2004 Feb;42(2):121-31
15061349
Science. 1986 Jan 24;231(4736):405-7
3941904
Circulation. 2004 Mar 2;109(8):1041-7
14967734